State Street Corp Merus N.V. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Merus N.V. stock. As of the latest transaction made, State Street Corp holds 241,116 shares of MRUS stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241,116

Previous 232,750 3.59%

Holding current value

$22.7 Million

Previous $9.8 Million 29.46%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$34.89 - $62.42 $291,889 - $522,205	8,366 Added 3.59%	241,116 $12.7 Million
Q1 2025 May 15, 2025	BUY	$39.01 - $49.16 $438,160 - $552,165	11,232 Added 5.07%	232,750 $9.8 Million
Q4 2024 Feb 14, 2025	SELL	$41.45 - $54.5 $1.39 Million - $1.83 Million	-33,546 Reduced 13.15%	221,518 $9.31 Million
Q3 2024 Nov 14, 2024	SELL	$47.19 - $58.84 $462,886 - $577,161	-9,809 Reduced 3.7%	255,064 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $804,042 - $1.22 Million	20,197 Added 8.25%	264,873 $15.7 Million
Q1 2024 May 15, 2024	BUY	$28.03 - $51.82 $251,933 - $465,758	8,988 Added 3.81%	244,676 $11 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $319,154 - $455,980	15,910 Added 7.24%	235,688 $6.48 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $269,923 - $365,931	13,409 Added 6.5%	219,778 $5.18 Million
Q2 2023 Aug 14, 2023	SELL	$18.33 - $27.18 $1.52 Million - $2.25 Million	-82,692 Reduced 28.61%	206,369 $5.43 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $112,945 - $162,483	7,926 Added 2.82%	289,061 $5.32 Million
Q4 2022 Feb 14, 2023	BUY	$12.8 - $23.66 $1.17 Million - $2.16 Million	91,228 Added 48.04%	281,135 $4.35 Million
Q3 2022 Nov 15, 2022	BUY	$18.64 - $28.93 $94,467 - $146,617	5,068 Added 2.74%	189,907 $3.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $123,135 - $257,634	8,808 Added 5.0%	184,839 $4.19 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $331,275 - $434,254	14,049 Added 8.67%	176,031 $4.65 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $920,980 - $1.49 Million	46,049 Added 39.72%	161,982 $5.15 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $90,079 - $148,839	5,466 Added 4.95%	115,933 $2.55 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $1.47 Million - $1.87 Million	73,495 Added 198.79%	110,467 $2.33 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $174,876 - $315,406	10,835 Added 41.45%	36,972 $772,000
Q4 2020 Feb 16, 2021	SELL	$11.4 - $18.36 $1,493 - $2,405	-131 Reduced 0.5%	26,137 $458,000
Q3 2020 Nov 10, 2020	BUY	$10.57 - $16.0 $135,190 - $204,640	12,790 Added 94.9%	26,268 $315,000
Q2 2020 Aug 14, 2020	BUY	$10.5 - $17.36 $141,519 - $233,978	13,478 New	13,478 $217,000

Others Institutions Holding MRUS

# of Institutions

217

Shares Held

65.3M

Call Options Held

311K

Put Options Held

556K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $4.32B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Merus N.V. Transaction History